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1H NMR-based metabonomics was used to investigate the multimodal response of mice to malarial parasite infection by P. berghei
ANKA. Liver metabolism was followed by NMR spectroscopy through the course of the disease in both male and female mice.
Our results showed alterations in the level of several metabolites as a result of the infection. Metabolites like kynurenic acid,
alanine, carnitine, and β-alanine showed significant alteration in the liver, suggesting altered kynurenic acid, glucose, fatty acid
and amino acid pathways. Distinct sexual dimorphism was also observed in the global analysis of the liver metabolic profiles.
Multiway principal component analysis (MPCA) was carried out on the liver, brain, and serum metabolic profile in order to
explore the correlation of liver and brain metabolic profile to the metabolite profile of serum. Changes in such correlation profile
also indicated distinct sexual dimorphism at the early stage of the disease. Indications are that the females are able to regulate
their metabolism in the liver in such a way to maintain homeostasis in the blood. In males, however, choline in liver showed
anticorrelation to choline content of serum indicating a higher phospholipid degradation process. The brain-serum correlation
profile showed an altered energy metabolism in both the sexes. The differential organellar responses during disease progression
have implications in malaria management.
1. Introduction
Plasmodium is the organism responsible for malaria. It
affects 200–300 million people and leads to a million deaths
annually [1], thereby posing a global threat. The clinical
symptoms of the infection are manifested during the blood
stage of the parasite life cycle in the human host [2]. In
acute stages of the disease, more than one tissue types are
known to be affected [2, 3]. It was shown that during this
stage of the disease, the parasitized RBCs show sequestration
thereby affecting the microvasculature of heart, kidney,
liver, intestines, adipose tissues, and eyes [4–6]. This may
result in localized metabolic stress. As the disease progresses
towards severity, several complications arise, possibly due
to the inflammatory immune response of the host which
result in complications such as liver damage, renal failure,
cerebral malaria, hypoglycemia and acidosis, some of which
may lead to death [7–9]. Although, the transition into
these conditions is poorly understood, all of them are
associated with different metabolic complications. Thus, one
approach towards understanding the disease progression is to
understand themetabolic alterations that occur as the disease
progresses towards severe stage. These alterations can be
monitored at single tissue or biofluid level and/or at the level
of the intertissue and/or tissue-biofluid correlation, where
one focuses onmore than one tissue/biofluid simultaneously.
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1H NMR spectroscopy of tissues and biofluids followed
by multivariate statistical analyses in a systems biological
approach has been widely used in understanding metabolic
changes [10]. 1H NMR spectra provide an unbiased profile
of metabolites present in the tissue or biofluids thereby pro-
viding a good platform for the study of different conditions
like breast cancer, diabetes, coronary artery disease, and
high blood pressure [11–14]. Metabolic response towards
parasitic infections has also been reported in the mouse
models of Trypanosome and Schistosome infection [15, 16].
Recently, our group has shown relevant metabolic links and
distinct sexual dimorphism with the progression of malaria
in the mouse model by NMR spectroscopy and multivariate
statistical analysis on urine, sera, and brain [17].
1H NMR spectra from a biofluid like serum or urine at
a single time point provide the snapshot of the molecular
phenotype or metabotype of the organism at a global level.
This, in principle, arises from the complex exchanges of
the metabolites among different compartments. Therefore,
the understanding of metabolic processes of multicellular
organisms at a global level requires the study of metabolic
correlations among the tissue and biofluidmetabolic profiles.
Sophisticated chemometric techniques have been developed
to address such problems. Montoliu et al. compared different
unsupervised chemometric techniques in order to study
intercompartmental metabolic analysis [18].
In this contribution, we report a NMR-based metabolite
profiling followed by the multivariate statistical analysis
strategy to delineate a distinct sexual dimorphism in the
liver metabolic profile in the mouse model (BALB/c mouse
infected with Plasmodium berghei ANKA) of malaria parasite
infection. Furthermore, employing an unsupervised chemo-
metric strategy (multiway principal component analysis-
MPCA), we show the correlation of brain and liver metabolic
profile with that of serummetabolic profile. The implications
of these results are also discussed.
2. Materials and Methods
2.1. Animal Experiments. The animals in the study were
treated in accordance with the prescribed guidelines of the
institutional animal ethics committee.
2.2. Collection and Extract Preparation of the Sera, Brain
and Liver Samples. The experiments were carried out in a
similar fashion as described elsewhere [17]. Briefly, 24 inbred
BALB/c mice (12 males and 12 females) aged 6 to 8 weeks
were used for the study. Eight male and female mice were
injected intraperitonally with 106 P. berghei ANKA-infected
erythrocytes. The remaining eight animals served as controls.
Four infected males, four infected females and four control
mice (two males and two females) were sacrificed on day 5
after infection. The rest of them were sacrificed on day 13
after infection. The animals were immediately dissected to
extract the liver out. The liver samples were snap frozen and
kept frozen until the preparation of perchloric acid extract as
described earlier [17]. The sera and brain sample collection
and extraction were done by the method described in [17].
2.3. NMR Spectroscopy of Tissue and Biofluid Extracts. 1H
NMR spectra were acquired on 700MHz spectrometer
(Bruker Biospin, Germany) equipped with broad band
inverse probe using 2-dimethyl-2-silapentane-5-sulfonic
acid (DSS) as an internal standard and the D2O as the field
frequency lock at 300K. The pulse sequence used included
an excitation sculpting routine for the suppression of the
water signal. 1024 transients were collected into 32,768 data
points using a spectral width of 12.01 ppm resulting in an
acquisition time of 1.94 s. A relaxation delay of 1 s was
used between consecutive pulses. The FIDs so obtained were
subjected to an exponential multiplication leading to an
additional line broadening of 0.2Hz. A sine bell apodization
function was used followed by the Fourier transformation.
The spectra were phase and baseline corrected manually and
used for further data reduction.
2D COSY spectra were obtained for the identification
of the metabolites in the following manner. In the direct
dimension, 64 transients were collected with 256 increments
in the indirect dimension. A QSINE function was used for
processing with 2048 and 1024 data points in direct and
indirect dimension, respectively.
2.4. Data Reduction. Two different data reduction pro-
cedures were followed. For the purpose of single tissue
analysis (liver, for our case), the spectral region 9.5 ppm to
0.5 ppm was segmented in frequency regions of 0.04 ppm,
and each bin was integrated using MestReC 4.7.0. The region
corresponding to water and urea (4.5 ppm to 6.5 ppm) was
excluded to avoid artifacts due to the water suppression and
highly variable urea. Certain regions of the spectra are known
to have high concentration metabolites with high variance
that maymask the important features in the peaks with lower
concentration. These regions were also excluded as described
earlier [17]. The resulting integrals were normalized to total
intensity and Pareto scaled to generate the working data
matrix.
For the purpose of the intercompartmental correlation
analysis, the binning procedure was done using Amix 5.0.
Here, a binning width of 0.003 ppm was used, and only the
water region was excluded (4.5 ppm to 5.1 ppm). The bins
were integrated and normalized with respect to the total
integral to generate the working data matrix.
2.5. Statistical Analyses
2.5.1. Multivariate Analysis on Liver Samples. The liver
spectra were subjected to the principal component analysis
(PCA) and orthogonal partial least square-discriminant
analysis (OPLS-DA), which were performed using Simca-P
12.0 (Umetrics, Sweden). Briefly, PCA is an unsupervised
method which is used for revealing any inherent trend or
pattern in the data set whereas, OPLS-DA is a supervised
method. Here, the class entity towards the sample set
is provided a priori, thereby showing the class-specific
distinction. Q2(cum) is the diagnostic parameter for the
OPLS-DA model which represents the separation of the
classes assigned. The models were set up in the following
ways: (1) using data from uninfected males and day 5
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post-infection males, (2) using data from uninfected males
and day 13 post-infection males, (3) same as (1) for females,
and (4) same as (3) for females. Initially, PCA was employed
(data not shown) in order to find out any hidden trend in the
data and to find outliers. This was followed byOPLS-DA. The
visualization was aided by two-dimensional scores plot that
shows the sample clustering in a two-dimensional space. The
variables contributing towards the clustering in the scores
plot were extracted using loadings S-plot and VIP plot.
The metabolites were identified using Human Metabolome
database (HMDB) along with the two-dimensional NMR
spectral profiles.
2.5.2. Peak Integration. After extracting the metabolites from
the multivariate analytical techniques (PCA and OPLS-DA),
individual peaks from the metabolites were selected in the
one-dimensional NMR spectra, and they were integrated
using Topspin 2.1. The crowding in the NMR spectral profile
sometimes resulted in overlap of the peaks. In those cases,
the metabolites are quoted together. The peak intensities of
individual metabolites were calculated with respect to the
intensity of internal standard DSS and normalized to the
total tissue weight. Significance test for comparison were
performed using Student’s t-test. Early- and late-stage infec-
tion time points were compared with uninfected controls of
the same sex. If the relative peak intensities of a metabolite
were comparable (P > .15) between male and female
uninfected samples, then a t-test was conducted to compare
males and females at each post-infection time point. If the
levels of the metabolite were different (P < .15) between
uninfected males and females, then from each post-infection
data point the value of the corresponding control average
was subtracted. An average of these normalized values was
taken and males and females were now compared for each
post-infection time point to determine if the deviation from
corresponding controls was significantly different between
them.
2.5.3. Intercompartmental Metabolic Correlation Analysis.
Multiway PCA (MPCA) as described elsewhere [18] was
used for the intercompartmental correlation analysis. Ini-
tially a Multivariate Curve Resolution-Alternating Least
Square algorithm (MCR-ALS) was employed to check the
relative contribution of the two relevant compartments.
Broadly, two kinds of intercompartmental analysis were
sought. (1) liver and serum and (2) brain and serum.
In each of these categories, three different models were
made for males and females, (a) controls, (b) day 5 after
infection, and (c) day 13 after infection. This helps in
the visualization of how the intercompartmental correlation
changes as the disease progresses. For this purpose, a 3D
matrix was prepared from the spectral integrals mentioned
earlier using Matlab 7.0.1. In this matrix, the rows are
the samples/animals, the columns are the spectral variables,
and the third mode is the tissues/biofluids. This matrix
was used for MPCA in Solo 5.8 (Eigenvector Inc.). The
mathematical details of the method can be found elsewhere
[18].
3. Results
Results for the serum and brain analysis have already been
discussed elsewhere [17]. Here, we report the alteration
of metabolic profile of liver and the intercompartmental
correlation of brain and liver with sera.
3.1. Changes in Liver Metabolic Profile with Progression of
the Disease. The liver extracts for the males showed no
perturbation when the early infection time points were
compared with uninfected animals (Q2(cum) = −0.882).
However, in the early infection time points, females showed
a large change from that of uninfected controls (Q2(cum) =
0.988). When the late-stage animals were compared with
the uninfected controls, drastic changes were observed
irrespective of the sex (Q2(cum for males = 0.975 and
Q2(cum) for females = 0.993). The representative scores
plot of the respective OPLS-DA models is shown in the
Figure 1. The VIP plots (See Supplementary Information 1
available at doi:10.1155/2011/901854) and loadings S-plot
(supplementary information 2) were further investigated in
order to extract the most significant spectral variables/bins.
These bins were further analyzed by the help of HMDB
and two-dimensional NMR spectral profiles to generate the
significant metabolites that contribute towards the pattern
seen in the OPLS-DA models. Table 1 shows a list of the
metabolites perturbed in the liver as the disease progresses
in both the sexes. However, as the early infection stage of
the males showed insignificant variation (Q2(cum)=−0.882,
Figure 1(a)) from the control animals, hence, metabolites
corresponding to that stage are not investigated. Further,
the specific peaks from the one-dimensional NMR profiles
were integrated with respect to the total intensity of the
internal standard (DSS). Many of the metabolites identified
from the OPLS-DA model showed statistically significant
difference as the disease progresses (Figure 2). Moreover,
analysis was done to compare some of the metabolites in
the two post-infection stages which were different in the
uninfected males and females to check whether they deviate
significantly from the same sex control. These are shown
in the Figure 3. OPLS-DA analysis of liver spectra showed
some of the metabolites (Table 1) which were not observed
in other tissues or biofluids [17]. However, although the
OPLS-DA analysis showed a large difference in the early
infection stage of females and uninfected controls (Table 1),
some of the metabolites that were expected to be increased
in the infected animals showed a large deviation in the VIP
(supplementary information 1). Therefore, OPLS-DA was
unable to predict the dramatic change in the early infected
females with certainty; hence, the early-stage changes in the
female liver remain to be characterized.
In the late stage, the liver extracts showed an increase in
2-hydroxy-2-methylbutyrate and beta-alanine (Figures 2(a)
and 2(e)) and a decrease in an unidentified compound at
3.82 ppm (Figure 2(f)) in both males and females. Along
with these, females showed increase in kynurenic acid in the
late stage (Figure 2(h)). Increase in two unidentified peaks
at 2.34 and 3.86 ppm was also shown by the females (Figures
2(b) and 2(g)).
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Table 1: Metabolites perturbed in the mouse liver during infection with P. berghei ANKA. Italicized metabolites could not be confirmed.
Cystine, serine and phosphoserine could not be confirmed because their crosspeaks occur in very crowded regions of the spectrum. Presence
of fatty acids cannot be confirmed due to low concentrations.
Increased compound
Chemical
shift
VIP
value
Loading Decreased compound
Chemical
shift
VIP
value
Loading
Females early stage
N-methyl-a-aminobutyric acid, Ribonolactone 3.82 3.01 0.242 Beta-alanine 3.18 5.66 −0.455
Dimethylglycine 3.7 2.85 0.229 O-phosphoethanolamine 4.02 2.5 −0.201
Phosphocreatine, Creatine, Betaine 3.9 2.72 0.219 Unidentified 3.66 2.12 −0.171
Unidentified 3.46 2.58 0.207 Sarcosine 3.62 2.84 −0.228
Alanine, methylacetoacetic acid, acetylcholine 3.74 1.91 Choline, Creatinine 4.06 2.37 −0.191
Choline, 3.5 1.5 0.153
3-hydroxyisovaleric acid, 4-pyridoxic acid 2.34 1.62 0.130
Female late stage
2-hydroxy-2-methylbutyric acid 0.94 3.01 0.242 Dimethylglycine 3.7 3.34 −0.268
2-ethylacrylic acid 0.98 2.41 0.194
N-methyl-a-aminobutyric
acid, ribonolactone
3.82 3.34 −0.268
Diethyl-thiophosphate,
O-phosphoethanolamine, Phosphoserine
3.98 2.38 0.191 Unconfirmed 3.46 3.28 −0.263
Beta-alanine 3.18 2.21 0.178
N-methyl-a-aminobutyric
acid,3-mercaptopyruvic
acid
3.86 3.05 −0.245
Dimethyl-sulphide, Acetyl-phosphate,
Amino-acetone, cis-2-methylaconitate
2.10 2.15 0.173
Alanine, methylacetoacetic
acid, acetylcholine
3.74 2.73 −0.219
Putrescine, L-leucine,
2-hydroxy-2-methylbutyric acid
1.7 2.03 0.163
Lactate,long chain fatty
acids
1.3 2.18 −0.175
3-hydroxyisovaleric acid, 4-pyridoxic acid 2.34 1.87 0.150 Glycine 3.54 2.13 −0.171
2-ethylacrylic acid, stearic acid 1.02 1.82 0.146
lactic acid,
N-acetyl-L-alanine
4.1 1.74 −0.140
Males late stage
Beta-alanine, Cystine 3.18 3.26 0.262
N-methyl-a-aminobutyric
acid,Ribonolactone
3.82 3.52 −.282
2-hydroxy-2-methyl-butyric acid 0.94 3.00 0.241
N-methyl-a-aminobutyric
acid,3-mercaptopyruvic
acid
3.86 3.38 −.271
2-ethylacrylic acid 0.98 2.44 0.196 Serine, Dimethylglycine 3.7 3.13 −.251
Dimethyl-sulphide, Acetyl-phosphate,
Amino-acetone, cis-2-methylaconitate
2.1 1.98 0.159
Alanine, methylacetoacetic
acid, acetylcholine
3.74 2.99 −.20
Putrescine, 2-hydroxy-2-methylbutyric acid,
L-leucine
1.7 1.95 0.156
Phosphocreatine, Creatine,
Betaine
3.9 2.44 −.196
2-ethylacrylic acid, stearic acid 1.02 1.77 0.142 cis-aconitic acid 3.46 2.33 −.187
Long-chain fatty acids 0.9 1.73 0.139
lactic acid,
N-acetyl-L-alanine
4.1 1.98 −.160
O-phosphoethanolamine, phosphoserine 3.98 1.73 0.139
Alanine, Acetylcholine,
guanidinoacetic acid
3.78 1.71 −.136
In spite of the poor difference shown in the OPLS-DA
between the male control and early-stage infected animals
(Figure 1), some of the metabolites showed significant
changes. These include asparagine, DMG, and creatine (Fig-
ures 2(c) and 2(d)), all of which are significantly decreased
from the control animals in the early stage.
Comparisons of the individual metabolite level of the
animals were also made with that of the controls (Figure 3),
and several interesting results were obtained. This was done
for the fact that several metabolites in the liver showed
significant difference in their levels between male and female
control animals (data not shown). Therefore, we investigated
whether the post-infection alterations are different between
males and females. Several of the changes observed in
such analysis were often only in the early-stage. Females
showed a slight increase from the corresponding controls,
while males showed a decrease in the carnitine level at this
stage (Figure 3(b)). Kynurenic acid levels in females did
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Figure 1: OPLS-DA scores plot based on the 1H NMR metabolic profile of the liver. The experiments consisted of 12 male and 12 female
mice. Eight male and 8 femalemice were injected with P. berghei ANKA. On day 5, 4 infected males, 4 infected females, 2 control males, and 2
control females were sacrificed, and the liver is extracted with perchloric acid (early-stage of infection). Again on day 13 (late-stage infection).
A/B, early- and late-stage infection males are compared with male controls; C/D, early- and late-stage infection females are compared with
female controls. In each plot, theQ2(cum) is shown at the bottom. The red triangle—profile of the infected animals and the black dots—the
control animals.
not change much from their controls whereas the males
showed a decrease (Figure 3(f)). Asparagine, DMG and
O-phosphoethanolamine levels were seen to be reduced
significantly more in the early stage infected male liver
samples as compared to females (Figures 3(c) and 3(e)).
Some distinct sexual dimorphism in the alteration of the
metabolite levels was observed. For example, an unidentified
peak at 2.34 ppm showed decrease in the males while slight
increase in the females compared to the corresponding
controls (Figure 3(a)). Similar trend was observed for
carnitine (Figure 3(b)), serine and DMG (Figure 3(d)).
Interesting here to note that is although the global
metabolic profile of the male controls does not differ much
from the male early infection animals, some of the individual
metabolites show a significant alteration (Figures 2(c), 2(d),
and 3). However, these alterations are possibly not enough
to have an impact on the differential global metabolic profile
(Figures 1(a) and 1(b)).
3.2. Intercompartmental Correlation Analysis by Multiway
PCA (MPCA). MPCA has been established as useful tool for
correlation analysis between tissues and circulating biofluids
[18]. In this paper, we have used the technique to delineate
the effect of disease progression on the correlation of
metabolites across tissues/biofluids. We used earlier data of
serum and brain [17] and the liver data described here
to investigate the correlations of metabolites in brain and
liver to that of serum with the disease progression in
both the sexes. Earlier studies made by our group [17]
showed that the brain metabolic profile is significantly
altered in both the sexes. Although this model of malaria
is not a cerebral variety, it is important to understand
how the brain metabolic profile varies with the circulating
biofluid. Initially, MCR-ALS algorithm (data not shown)
was employed that showed appreciable contribution of one
compartment on the spectrotype of the other. Earlier studies
also found appreciable contribution of the blood serum
6 Journal of Parasitology Research
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Figure 2: Perturbed metabolite levels in mouse liver at early- and late-stage malarial infection. All peak intensities have been calculated
relative to the peak height of 0.132mg/mlDSS present in every sample. Panels showing two metabolites represent overlapping 1H NMR
resonances at the chemical shift mentioned. Where only chemical shifts are mentioned, identity of metabolites could not be confirmed.
Black = males and grey = females. ∗ indicates P < .05, + indicates P < .08 in comparison to the uninfected controls of the same sex.
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Figure 3: Perturbed metabolite levels in mouse liver at early- and late-stage malarial infection: comparison of effects in male and female
animals. The average peak intensity for the metabolite in uninfected samples of the same sex was subtracted from individual peak intensities
of infected animals at each stage of infection. The average change in intensity with respect to the same sex control is plotted here. ∗
indicates P < .05, + indicates P < .08 in comparison to the males at each stage. Black = male, and grey = female. Panels showing two
metabolites represent overlapping 1H NMR resonances at the chemical shift mentioned. Where only chemical shifts are mentioned, identity
of metabolites could not be confirmed.
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Table 2: MPCA model statistics in terms of total explained
variances by two PCs calculated in percentage.
Model Total variation explained (%)
Liver-serum correlation, female
Control 93.17
Early infection 98.15
Late infection 99.25
Liver- serum correlation, male
Control 96.40
Early infection 99.02
Late infection 98.08
Brain- serum correlation, female
Control 94.55
Early infection 98.81
Late infection 99.25
Brain- serum correlation, male
Control 96.72
Early infection 98.02
Late infection 98.58
spectrotype to the liver [18]. Further, MPCA models were
built using the NMR metabolite profiles of the sera and the
relevant tissue from a set of animals (e.g., 4 female controls,
sera, and brain NMR metabolite profile). 12 such models
were generated (control, early- and late-stage infection for
males and females) for both types of correlations (brain-
sera and liver-sera) to be addressed. The first two principal
components (PCs) were calculated for each of them. Table 2
shows the amount of variation explained by the models.
All of them explained >90% of cumulative variance. The
loadings in PC2 described the correlation of the NMR
spectral peaks across the relevant tissue (either liver or brain)
and serum.
In female control animals, high concentration of
branched chain amino acids (BCAA) (1) leucine, isoleucine,
valine, choline (2) and a low concentration of glucose (3)
in the liver were associated with low lactate (4), glucose (3)
and high concentration of lysine (5) in serum (Figure 4(a)).
There was a peak at 3.20 ppm (close to choline peak) which
could not be identified. The females at early-stage infection
showed essentially a similar serum profile to that of control
animals, with an exception of a high dimethylamine (DMA)
(9) in the serum (Figure 4(b)). However, the liver profile of
these animals showed high branched chain amino acids (1),
alanine (6), trimethylamine-N-oxide (TMAO) (7), glycine
(8) and lactate (4) (Figure 4(b)). In the late-stage infection of
the females, the liver showed a high choline (2) and glucose
(3) which were associated with low lactate (4) and high
glucose (3) level in the serum (Figure 4(c)).
Male control animals showed a different profile than
that of the females. In the liver of the male control animals
isoleucine (1 as BCAA), leucine (1 as BCAA), lactate (4),
choline (2) and, TMAO (7) were low and glucose (3) was
high. These were correlated to a low lactate (4) and high
DMA (9) in the serum (Figure 4(d)). When the early-stage
infection for the male animals was considered, the liver
profile showed increase in BCAA (1), alanine (6), choline
(2), and lactate (4) compared to the control animals, with
the contribution of TMAO (7) becoming insignificant. The
serum profile for this group of animals showed a high DMA
(9) and low choline (2) level with respect to the liver profile
(Figure 4(e)). The late-stage infection for the males was also
relatively simple with low glucose (3) in liver being associated
to high glucose (3), lactate (4) and low branched chain amino
acids (1) in the serum (Figure 4(f)).
Our earlier studies (15) showed a significant deviation
of the brain metabolic profile in the early-stage infection
as well as the late-stage infection from the control animals.
Thus, it would be interesting to see whether the serum-
brain intercompartmental correlation is also affected with
the disease progression. Therefore, the correlation of the
brain metabolic profile with that of serum was assessed in
order to delineate the crosstalk between these two biological
compartments. The female control animals showed a high
lactate (4), N-acetyl-aspartate (NAA, 10), sarcosine (11),
and low choline (2) in the brain that correlated with high
lysine (5) and low lactate (4) and glucose (3) in the serum
(Figure 5(a)). In the early infection, the brain profile showed
high lactate (4), DMA (9), creatine (12), and betaine (13).
However, the serum profile remained similar to that of
controls, although it showed a high DMA (9) (Figure 5(b)).
In the late-stage, the brain metabolic profile showed high
values of lactate (4), NAA (10), DMA (9), creatine (12), and
choline (2). These were found to be significantly correlated
with the high glucose (3) and low lactate (4) in the serum
(Figure 5(c)).
The male metabolic intercompartmental analysis was
also performed. The male controls, as expected, were differ-
ent from that of females. They showed a low lactate (4), NAA
(10), DMA (9), choline (2), and creatine (12) in the brain
profile associated to a low lactate (4) and high DMA (9) in
the serum (Figure 5(d)). The males showed change in the
serum profile only in terms of a high lactate and low choline
level, and the rest of the profile remained quite similar at the
early-stage infection. At this stage, they showed a low creatine
(12) and high DMA (9) in the brain (Figure 5(e)). The late
infection stage showed a low lactate (4), high creatine (12),
and DMA (9) in the brain and high lactate (4), glucose (3)
and low BCAA in the serum (Figure 5(f)).
Figure 4 (liver-serum correlation) and Figure 5 (brain-
serum correlation) show a comprehensive visualization of
all the increased and decreased metabolites in different
compartments during the various stages of the disease.
Important to note here is that the set of metabolites that were
found to be significant from the OPLS-DA (Table 1, Figures
2 and 3 for liver metabolites and [17] for brain metabolites)
study are different from those found from MPCA (Figures
4 and 5). It is important to realize at this point that OPLS-
DA showed a set of metabolites that were significantly altered
among the infected and control sets in a single tissue or
biofluid. However, MPCA resulted in a set of metabolites
which are significant in terms of the intercompartmental
correlation.
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Figure 4: The liver and serum correlation profile depicted byMPCA PC2 loadings plot. The aliphatic region of the spectra is shown. (a–c) are
females and (d–f) are the males. In each set, the left figure is the liver profile and the right one is the serum profile. The y-axis in each panel
represents the loading axis. The compartmental loadings are obtained by cropping the model loading. (a/d): control, (b/e): early infection,
and (c/f): late infection. Symbols: 1: branched chain amino acids, 2: choline, 3: glucose, 4: lactate, 5: lysine, 6: alanine, 7: trimethylamine
oxide (TMAO), 8: glycine, 9: dimethylamine, and u: unidentified peak.
4. Discussion
In this paper, we report our results on the alterations of the
liver metabolism during the progress of malaria as well as the
change in the correlation of the metabolic profile of the liver
and brain with that of blood serum as the disease progresses.
Murine model (BALB/cmice infected with P. berghei ANKA)
using animals from both the sexes used for this purpose.
Earlier results from our group [17] suggested that the host
response towards the infection exhibits sexual dimorphism
in the urine and serum metabolic profile. The alteration of
the liver metabolism during the disease progression supports
this fact. The liver profile in the female mice was altered in the
early stage of the disease as compared to the males (Figure 1).
Liver being the regulatory organ for metabolic activities, a
drastic change in its metabolic profile in the early stage of
the disease raises the possibility that the female hosts are able
to respond to the infection by maintaining the homeostasis
within them. This is supported by our earlier result that the
female hosts show no early changes of the metabolic profile
of the serum [17], while themales do. At the late stage, drastic
changes in the metabolic alteration are observed irrespective
of the sex of the host (Figure 1), which is anticipated because
of the fact that the animals are very ill at this time point.
Our earlier findings [17] indicated several alterations in
themetabolic pathways during the progression of the disease.
Among them, glucose metabolism, amino acid metabolism,
kynurenine pathway, uracil degradation, and fatty acid
metabolism were found to be significant. These observations
were based on the alteration on the urine, sera, and brain
metabolic profile. Our data on the liver metabolism reported
here is in good agreement with that.
Glucose metabolism is known to be perturbed during
malaria parasite infection largely due to the enhanced
rate of glycolysis [19–21]. Lactic acidosis is an important
pathophysiological feature of malaria. Our earlier results
in the serum and brain metabolic profile showed a sexual
dimorphism in lactate levels of those tissues. However, the
comparison made with the liver metabolic profile does not
show a pronounced increase in the lactate level. Instead, in
the late-stage the lactate in the liver is shown to be decreased
in males as well as females (Table 1). Enhancement of rate
of glycolysis leads to an increased formation of pyruvate
which may be transaminated to alanine. Thus, the change
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Figure 5: The brain and serum correlation profile depicted by MPCA PC2 loadings plot. The aliphatic region of the spectra is shown. The
panels (a–c) are the females and (d–f) are the males. In each set, the left figure is the brain profile and the right is the serum profile. The
y-axis in each panel represents the loading axis. The compartmental loadings are obtained by cropping the model loading. (a/d): control,
(b/e): early infection, and (c/f): late-infection. Symbols: 10: N-acetylaspartate, 11: sarcosine, 12: creatine, 13: betaine, u: unidentified peak.
in the level of alanine is important in this regard. Alanine
did not show the trend like lactate (Table 1). In the early-
stage female animals, alanine is increased compared to the
controls. The change in the alanine level is an indicator of
the alteration of circulating amino acid levels. [17]. Liver
being the metabolic regulatory organ, alteration in the level
of the amino acids in the liver is expected. Along with
alanine, the level of serine is also seen to be altered in
the liver extracts. In the males, it is decreased, and in the
females, the level is increased marginally when compared
to the corresponding control thereby showing a sexual
dimorphism (Figure 3(d)). Asparagine level also showed
a significantly greater decrease in the males compared to
the females with respect to the corresponding controls
(Figure 3(c)). Plasmodium sp. are known to incorporate
disproportionately a large amount of asparagine in their
proteome in the ubiquitous low-complexity region [22].
Along with the amino acid mentioned, leucine levels was
also increased in both males and females in the late stage
(Table 1). However, alteration in the branched chain amino
acids and aromatic amino acids were reported in context of
Trypanosome infection also [23, 24].
Our earlier findings [17] showed a perturbation in
the kynurenine pathway. We were the first to observe the
increased excretion of kynurenic acid (KA) and quinolinic
acid in the male infected mice. In the sera and brain,
they showed a pronounced sexual dimorphism. When liver
extracts are considered, KA exhibited a sexual dimorphism
in the early-stage liver that its level in the infected male
liver extracts decreased, while those in female did not
(Figure 2(h)). The kynurenine pathway is activated by the
immunological factor IFN-γ; therefore; it is systematically
upregulated during the activation of the immune response
under multiple disease condition [25]. Therefore, an inter-
esting question that remains to be asked is whether the
sexual dimorphism that we see in the pathway is a cause for
the differential immunological activation between males and
females.
Several components of fatty acid metabolic pathway are
indicated to be perturbed in the liver extracts. A rise in fatty
acid concentration in the male and female liver is indicated
by the 0.9 ppm peak (Table 1). Oxidation of these fatty acids
would entail generation of carnitine which we reported to be
decreased in the urine of female mice [17]. This suggests a
selectively higher retention of this metabolite for the cellular
β-oxidation. The liver levels of carnitine also showed a sexual
dimorphism in the early stage (Figure 3(b)). Whereas the
males showed a slight decrease, the females demonstrated
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a slight increase from the corresponding controls. Along
with this, choline was indicated to be increased in the early-
stage infected females (Table 1). O-phosphoethanolamine
was detected in the liver sample to show a sexual dimorphism
in the late stage (Figure 3(e)) along with 2-hydroxy-2-
methylbutyrate which was increased significantly in both the
sexes in the late stage (Figure 2(a)).
The crosstalk (correlation) of metabolites across organs
and biofluids is an important parameter in their changing
dynamical interaction during disease progression. For this
purpose, we analyzed the correlation of the liver and brain
metabolic profile with that of blood serum. Previously, we
delineated the effect of disease progression on the brain
metabolic profile individually [17]. Important to note is
that at the late stage of infection, the correlation profiles
look drastically different than that of the controls (Figures
4(c), 4(f), 5(c), and 5(f)). This is expected because of
the enhanced severity of the disease. Therefore, we would
concentrate more on the early-stage correlation profile. As
noted earlier the liver serum correlation of the female animal
is distinct from that of the males in the control animals
(Figures 4(a) and 4(d)). Initial study on the liver profile of
the control animals showed no distinction between the two
sexes (data not shown), and similar results were observed for
the serum profile [17]. Thus, it is evident that the dynamic
intercompartmental correlation is maintained differently in
the two sexes which result in similar global metabolic profile
of the individual compartment. For example, in both of
them, the amino acids (1) in the liver are anticorrelated
to the glucose (3) in the liver. This possibly refers to the
gluconeogenetic pathway. However, the females and males
show different modes of correlation. Males showed a low
amino acid concentration to be correlated to a high glucose
concentration (Figure 4(d)) whereas females showed the
opposite (Figure 4(a)). In addition, males showed a low
serum lactate (4) to be correlated with high liver glucose
(3) (Figure 4(d)), and females showed a low serum lactate
(4) to be correlated with low liver glucose (3). This suggests
a complex glycolytic-gluconeogenetic relationship which
keeps the global metabolic profile of the individual tissue
and/or biofluid more or less similar between the two sexes.
The data presented here also suggests that this correlation
is compromised during the course of the disease in some
way or another. For the females in the early stage, the serum
compartment of the correlation profile looks more or less
the same except for an increased contribution from the DMA
(9), whereas there are notable changes in the liver segments
of the profile (Figures 4(a) and 4(b)). However, in the
males, both serum and liver segment showed notable changes
(Figures 4(d) and 4(e)). Therefore, we observe a sexual
dimorphism even in the intercompartmental correlation
status when the liver and serum are considered. This may
implicate that the amount of circulating metabolites in the
females remain under homeostasis, while their metabolism
in the liver is altered drastically. This supports the hypothesis
that there is significant amount of change in the early-stage
female liver in order to maintain the homeostasis in the
circulating fluid in response to the pathogen. In the female
early-stage infection an increased alanine (6), TMAO (7),
glycine (8), and lactate (4) in the liver were correlated with
an increased DMA (9) in the serum. DMA is a metabolic
product of TMAO, so an increased DMA in the serum
can be correlated with an increased TMAO in the liver.
TMAO has been reported to be associated with kidney
disease [26] and is used by the body as an osmolyte to
counter-act the accumulation of urea due to renal failure.
This refers to the fact that the females can or at least
try to maintain other organs under functional state at the
early stage of the disease. As noted earlier, lactate did not
show a significant contribution towards the differentiation
of infected and control animals; however, in the correlation
analysis, we observe an inverse relation of the liver and
serum lactate for the early-stage females (Figure 4(b)). Here,
a relative buildup in the liver lactate is associated with the
depletion of the serum lactate. Lactate is a gluconeogenic
precursor in the liver. It is possible that the heavy utilization
of glucose in the blood is counteracted by the host by
enhancing the rate of gluconeogenesis in the liver. However,
if that is the case, then one would expect an opposite
relation between the liver and serum lactate to that we see
here. Gluconeogenesis is enhanced in the severe malaria
patients [27]. This study also reported an enhancement of
serum lactate. Our result, therefore, suggests a more intricate
functional and spatiotemporal relationship between the liver
and serum lactate. For example, it might be possible that an
alteration in the Cori cycle pathway changes the uptake of
lactate from serum into liver. However, the details of this
process remain to be investigated. In males, however, both
the liver and serum profile changes in the early stage of
infection (Figure 4(e)), referring to the fact that the males
are unable to maintain the blood homeostasis. Moreover,
the liver metabolism of these animals is altered drastically.
Here, the choline of liver is found to be anticorrelated to
the choline of serum. Precisely, an increased choline in the
liver is associated with a decreased choline in the serum. This
may be due to the fact that the intraerythrocytic parasite
causes a 5-fold increase in the phospholipid content of
the parasitized cell [28], which may eventually lead to a
phospholipid degradation in the liver of the host, thereby
generating more of the phosphocholine components.
As far as the brain to serum correlation analysis is
concerned, for the females, the contribution from the serum
towards the brain-serum crosstalk does not alter much;
however, the brain profile did change notably (Figures 5(a)
and 5(b)). For the males, both the brain and serum profile
was altered (Figures 5(d) and 5(e)), although the early-stage
brain profile looks similar to that of control animals. Earlier
report showed that the brain profile in the early-stage males
and females did not change significantly [17]. However, this
data suggests that the brain profile is maintained by the aid
of a complex relationship with the serum. In the females, as
noted earlier, the homeostasis of the serum is maintained,
while for the males, the brain profile is maintained at the
cost of serum homeostasis. In females, the brain showed a
relative increase in the lactate and creatine, whereas themales
showed a relative decrease of creatine. This indicates that the
energy metabolism of the brain is altered in the early stage
of the infection in both sexes. However, the alteration in the
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energy metabolism probably bears different meanings in the
two sexes. In the males, this is an effect of the maintenance of
brain homeostasis at the cost of serum homeostasis, whereas,
for the females it is the other way around.
This paper presents the initial understanding of the
complex interplay of the various biological compartments
during the progression of malaria in mice. This, therefore,
opens up the possibility of a greater insight into the changes
in the metabolic pathways as a response to malarial parasite
infection.
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